Alexion Pharmaceuticals, Inc.
Lysosomal acid lipase deficiency compositions and methods

Abstract:

Compositions and methods relating to potentially pathogenic mutations in the nucleotide sequence of a human LIPA gene. Some LIPA gene products have been discovered to be associated with reduced lysosomal acid lipase (LAL) activity.